Every protocol starts with your data.
Diagnostics first. Prescriptions only when the biomarkers support them. Here is what we offer and how each intervention fits a monitored, individualized protocol.
Biomarkers before prescriptions
InBody body composition analysis and comprehensive biomarker bloodwork establish your baseline. We read what is actually happening physiologically before any protocol is written.
Tracked metrics include muscle mass, visceral fat index, hormonal panels, inflammatory markers, and metabolic indicators — the full picture, not a single number.
Monitored medications, not just supplements
Peptide Therapy
GLP-1 Medications
Adjunct Therapies
Clinician-selected peptides — including BPC-157, CJC-1295, and Ipamorelin — prescribed based on your biomarker results and monitored for measurable outcomes.
Semaglutide and tirzepatide protocols prescribed within a structured clinical framework — dosing adjusted against InBody data, not a static starting template.
Hormone optimization, nutrient repletion, and metabolic support agents prescribed alongside primary protocols — each selection justified by your lab results.
Functional Medicine
Treat the system, not the symptom
Root-cause analysis means tracing dysfunction back to its origin — gut health, hormonal dysregulation, chronic inflammation, or metabolic disruption — and designing a protocol around that finding.